840 



Mr. Wyden. The fact of the matter is that these Federal task 

 forces indicate that it is technically and economically feasible. I've 

 heard the head of the Consumer Product Safety Commission ex- 

 press great frustration over the inability to get these products out. 



Again, what we've got is a situation where independent experts 

 say it can be done and people with a vested interest and economic 

 interest say otherwise. That is of course, the pattern of what we 

 have seen today. It started, I guess, Mr. Chairman, more than 6 

 hours ago, where we began to talk about whether nicotine was ad- 

 dictive. I brought out and our colleagues did all these studies, all 

 these experts, saying nicotine was addictive. 



What we found, lo and behold, is the one organized body of 

 thought that says it's not are people with a financial interest to say 

 that nicotine is not addictive. That pattern has continued through 

 the day. 



I'm hopeful that today's hearing will help us build support for 

 the important legislation and work of the committee. Mr. Chair- 

 man, I want to thank you and the staff for a hearing of more than 

 6 hours and I think it's brought to light many important issues for 

 the public. 



Mr. Waxman. Thank you, Mr. Wyden. First of all, I want to ask 

 unanimous consent that we leave the record open. We may have 

 additional requests for documents, which we would like to put in 

 the record. I'd like to ask this panel, if you would, to answer addi- 

 tional questions from members of the committee, should there be 

 any, in writing for the record. 



We will keep the record open for that purpose. I appreciated Mr. 

 Campbell's willingness to allow Dr. DeNoble to present scientific 

 and medical information. I would request that if we have individ- 

 uals who have conducted scientific or medical research in conjunc- 

 tion with your corporations, that you cooperate with us so that we 

 will have the benefit of that information, as well as has Philip Mor- 

 ris done in regard to this one researcher. 



Let me tell you, in closing, that it's been a long day. We've gone 

 through many different subjects. These are important areas for in- 

 quiry. We haven't resolved, obviously, the disputes that we have, 

 but I think we got a lot of information on the table and I hope a 

 new basis for which we can work together to resolve those issues, 

 where we will be able to agree in the future, because it's in the 

 public interest. 



Mr. Bliley? 



Mr. Bliley. I want to thank these gentlemen and their compa- 

 nies for coming. I think you've been most forthcoming with this 

 committee and I know it's been a long day. Thank you, gentlemen. 



Mr. Waxman. Thank you. That concludes our business for today 

 and we stand adjourned. 



[Whereupon, at 3:20 p.m., the subcommittee was adjourned, to 

 reconvene at the call of the Chair.] 



[The following letter was received for the record:] 



